TG Therapeutics (TGTX) executive compensation, 2026 proxy

Michael S. Weiss, Chief Executive Officer and President, was paid $25.6M in 2025, up 36% from $18.8M the year before. The CEO-to-median-employee pay ratio was 67:1, on median employee pay of $306,004.

Filed
April 30, 2026
Annual meeting
June 11, 2026
Pay year
2025
Named executives
2
CEO total pay
$25.6M+36% vs prior year
CEO to median employee
67:1median $306,004
CEO pay in equity
92%$23.6M in awards
CEO Target Bonus
100%Percentage of base salary
CEO Stock Awards
$23.6MGranted under 2022 Incentive Plan
Median Employee Pay
$306,004Based on 2025 Box 1 W-2

How Weiss was paid

$25.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary3%Stock awards92%Non-equity incentive4%

Named executive officers

ExecutiveTotal
Michael S. WeissChief Executive Officer and President$25,571,250
Sean A. PowerChief Financial Officer, Treasurer and Corporate Secretary$3,768,375

What changed and why

  • $25.6MCEO total compensation increased to $25,571,250 in 2025 from $18,752,897 in 2024.
  • $23.6MStock awards for the CEO were valued at $23,550,000 for fiscal 2025.
  • $1.1MNon-equity incentive plan compensation for the CEO was $1,146,250 for 2025.
  • $875KThe CEO's base salary remained unchanged at $875,000 in 2025.
  • The ratio of the CEO to median employee pay was 67 to 1.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.